<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font3" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font4" size="10" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font5" size="7" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font6" size="8" family="AkzidenzGroteskBE" color="#ffffff"/>
	<fontspec id="font7" size="9" family="RVLYQS+TimesNewRoman" color="#000000"/>
	<fontspec id="font8" size="8" family="RVLYQS+TimesNewRoman" color="#000000"/>
	<fontspec id="font9" size="11" family="RVLYQS+TimesNewRoman" color="#000000"/>
	<fontspec id="font10" size="11" family="RVLYQS+Symbol" color="#000000"/>
	<fontspec id="font11" size="10" family="RVLYQS+TimesNewRoman" color="#000000"/>
	<fontspec id="font12" size="6" family="AkzidenzGroteskBE" color="#ffffff"/>
	<fontspec id="font13" size="6" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font14" size="8" family="VWTZZY+TimesNewRoman" color="#000000"/>
	<fontspec id="font15" size="8" family="PNMLKZ+Symbol" color="#000000"/>
	<fontspec id="font16" size="9" family="VWTZZY+TimesNewRoman" color="#000000"/>
	<fontspec id="font17" size="6" family="VWTZZY+TimesNewRoman" color="#000000"/>
<text top="42" left="315" width="62" height="7" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="text"><b>Available online</b></text>
<text top="42" left="380" width="176" height="7" font="font2" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="text">http://breast-cancer-research.com/content/7/1/R19</text>
<text top="735" left="569" width="14" height="8" font="font3" id="p1_t3" reading_order_no="161" segment_no="1" tag_type="text">R25</text>
<text top="355" left="57" width="240" height="9" font="font4" id="p1_t4" reading_order_no="42" segment_no="8" tag_type="text">survival in patients with early-stage breast cancer <a href="">[23</a>,<a href="">24</a>].</text>
<text top="367" left="57" width="240" height="9" font="font4" id="p1_t5" reading_order_no="43" segment_no="8" tag_type="text">Treatment options for early-stage breast cancer include</text>
<text top="379" left="57" width="240" height="9" font="font4" id="p1_t6" reading_order_no="44" segment_no="8" tag_type="text">chemotherapy (e.g. anthrocyclines, taxanes) and hormone</text>
<text top="391" left="57" width="240" height="9" font="font4" id="p1_t7" reading_order_no="45" segment_no="8" tag_type="text">therapy (e.g. tamoxifen, aromatase inhibitor). Estrogen</text>
<text top="402" left="57" width="241" height="9" font="font4" id="p1_t8" reading_order_no="46" segment_no="8" tag_type="text">mediates its functions through two specific intracellular</text>
<text top="414" left="57" width="240" height="9" font="font4" id="p1_t9" reading_order_no="47" segment_no="8" tag_type="text">receptors, estrogen receptor alpha and estrogen receptor</text>
<text top="426" left="57" width="240" height="9" font="font4" id="p1_t10" reading_order_no="48" segment_no="8" tag_type="text">beta, which act as hormone-dependent transcriptional reg-</text>
<text top="438" left="57" width="240" height="9" font="font4" id="p1_t11" reading_order_no="49" segment_no="8" tag_type="text">ulat<a href="">ors [25,26]. </a>The estrogen receptor pathway plays a crit-</text>
<text top="449" left="57" width="240" height="9" font="font4" id="p1_t12" reading_order_no="50" segment_no="8" tag_type="text">ical role in the pathophysiology of human breast cancer.</text>
<text top="461" left="57" width="240" height="9" font="font4" id="p1_t13" reading_order_no="51" segment_no="8" tag_type="text">Overexpression of estrogen receptor alpha is a well-estab-</text>
<text top="473" left="57" width="241" height="9" font="font4" id="p1_t14" reading_order_no="52" segment_no="8" tag_type="text">lished prognostic and predictive factor in breast cancer</text>
<text top="485" left="57" width="240" height="9" font="font4" id="p1_t15" reading_order_no="53" segment_no="8" tag_type="text">patients. The prognostic significance of estrogen receptor</text>
<text top="496" left="57" width="132" height="9" font="font4" id="p1_t16" reading_order_no="54" segment_no="8" tag_type="text">beta is not we<a href="">ll defined [27-30].</a></text>
<text top="520" left="57" width="240" height="9" font="font4" id="p1_t17" reading_order_no="55" segment_no="10" tag_type="text">Our previous study on the different series of bis-aziridinyl-</text>
<text top="532" left="57" width="240" height="9" font="font4" id="p1_t18" reading_order_no="56" segment_no="10" tag_type="text">naphthoquinone compounds identified that they exhibit a</text>
<text top="543" left="57" width="240" height="9" font="font4" id="p1_t19" reading_order_no="57" segment_no="10" tag_type="text">more potent response toward the solid tumors than the cir-</text>
<text top="555" left="57" width="240" height="9" font="font4" id="p1_t20" reading_order_no="58" segment_no="10" tag_type="text"><a href="">culation tumors [17]. Thi</a>s result was supported by other</text>
<text top="567" left="57" width="240" height="9" font="font4" id="p1_t21" reading_order_no="59" segment_no="10" tag_type="text">reports that there are differences in the reductive</text>
<text top="579" left="57" width="240" height="9" font="font4" id="p1_t22" reading_order_no="60" segment_no="10" tag_type="text">metabolism between the solid tumors and the circulation</text>
<text top="590" left="57" width="241" height="9" font="font4" id="p1_t23" reading_order_no="61" segment_no="10" tag_type="text">tumors<a href=""> [2]</a>. Considering the importance of all the cellular</text>
<text top="602" left="57" width="240" height="9" font="font4" id="p1_t24" reading_order_no="62" segment_no="10" tag_type="text">reductases (e.g. NADPH cytochrome P450 reductase,</text>
<text top="614" left="57" width="240" height="9" font="font4" id="p1_t25" reading_order_no="63" segment_no="10" tag_type="text">cytochrome b5 reductase, [NADP]H oxidoreductase,</text>
<text top="626" left="57" width="240" height="9" font="font4" id="p1_t26" reading_order_no="64" segment_no="10" tag_type="text">NQO1) in response to the whole cellular reductive metab-</text>
<text top="637" left="57" width="241" height="9" font="font4" id="p1_t27" reading_order_no="65" segment_no="10" tag_type="text">olism, these reductases are probably involved in bioactiva-</text>
<text top="649" left="57" width="240" height="9" font="font4" id="p1_t28" reading_order_no="66" segment_no="10" tag_type="text">tion of AZ-1. The bioreductive drugs AZQ, mitomycin C and</text>
<text top="661" left="57" width="241" height="9" font="font4" id="p1_t29" reading_order_no="67" segment_no="10" tag_type="text">E09, however, have been developed to exploit the oxygen</text>
<text top="673" left="57" width="240" height="9" font="font4" id="p1_t30" reading_order_no="68" segment_no="10" tag_type="text">deficiency in the hypoxic fraction of solid tumors on the</text>
<text top="684" left="57" width="240" height="9" font="font4" id="p1_t31" reading_order_no="69" segment_no="10" tag_type="text">premise that hypoxic cells should show a greater propen-</text>
<text top="696" left="57" width="241" height="9" font="font4" id="p1_t32" reading_order_no="70" segment_no="10" tag_type="text">sity for reductive metabolism than well-oxygenated cells</text>
<text top="708" left="57" width="42" height="9" font="font4" id="p1_t33" reading_order_no="71" segment_no="10" tag_type="text"><a href="">[2,31-33</a>].</text>
<text top="367" left="315" width="241" height="9" font="font4" id="p1_t34" reading_order_no="129" segment_no="9" tag_type="text">The major events involved in tissue homeostasis are prolif-</text>
<text top="379" left="315" width="240" height="9" font="font4" id="p1_t35" reading_order_no="130" segment_no="9" tag_type="text">eration, differentiation, and apoptosis. The processes of</text>
<text top="391" left="315" width="241" height="9" font="font4" id="p1_t36" reading_order_no="131" segment_no="9" tag_type="text">cell reproduction normally take place through an ordered</text>
<text top="402" left="315" width="241" height="9" font="font4" id="p1_t37" reading_order_no="132" segment_no="9" tag_type="text">process, generally known as the cell cycle. The tumor</text>
<text top="414" left="315" width="240" height="9" font="font4" id="p1_t38" reading_order_no="133" segment_no="9" tag_type="text">suppressor gene p53 is a multifunctional protein mainly</text>
<text top="426" left="315" width="241" height="9" font="font4" id="p1_t39" reading_order_no="134" segment_no="9" tag_type="text">responsible for maintaining genomic integrity, and it is the</text>
<text top="438" left="315" width="241" height="9" font="font4" id="p1_t40" reading_order_no="135" segment_no="9" tag_type="text">most frequently mutated gene in human tu<a href="">mors [34]</a>. In</text>
<text top="449" left="315" width="240" height="9" font="font4" id="p1_t41" reading_order_no="136" segment_no="9" tag_type="text">response to DNA damage, aberrant growth signals, or</text>
<text top="461" left="315" width="240" height="9" font="font4" id="p1_t42" reading_order_no="137" segment_no="9" tag_type="text">chemotherapeutic drugs, p53 is stabilized and induces</text>
<text top="473" left="315" width="240" height="9" font="font4" id="p1_t43" reading_order_no="138" segment_no="9" tag_type="text">apoptosis and/or cell cycle arrest. While the mechanisms</text>
<text top="485" left="315" width="240" height="9" font="font4" id="p1_t44" reading_order_no="139" segment_no="9" tag_type="text">of p53-dependent apoptosis are not understood well, p53-</text>
<text top="496" left="315" width="241" height="9" font="font4" id="p1_t45" reading_order_no="140" segment_no="9" tag_type="text">dependent cycle arrest is primarily mediated by the cdk</text>
<text top="508" left="315" width="240" height="9" font="font4" id="p1_t46" reading_order_no="141" segment_no="9" tag_type="text">inhibito<a href="">r p21 [34-36]. </a>p21 regulates the cellular repair</text>
<text top="520" left="315" width="135" height="9" font="font4" id="p1_t47" reading_order_no="142" segment_no="9" tag_type="text">resp<a href="">onse to damaged DNA [37].</a></text>
<text top="543" left="315" width="240" height="9" font="font4" id="p1_t48" reading_order_no="143" segment_no="11" tag_type="text">In the cytotoxicity results, AZ-1 induced the death effect of</text>
<text top="555" left="315" width="240" height="9" font="font4" id="p1_t49" reading_order_no="144" segment_no="11" tag_type="text">BC-M1 cells and MCF-7 cells in a dose-dependent and</text>
<text top="567" left="315" width="240" height="9" font="font4" id="p1_t50" reading_order_no="145" segment_no="11" tag_type="text">time-dependent manner in BC-M1 cells (F<a href="">igs 1 an</a>d <a href="">2</a>).</text>
<text top="579" left="315" width="241" height="9" font="font4" id="p1_t51" reading_order_no="146" segment_no="11" tag_type="text">From the results shown in Fig. <a href="">3, th</a>e hormone antagonist</text>
<text top="590" left="315" width="240" height="9" font="font4" id="p1_t52" reading_order_no="147" segment_no="11" tag_type="text">taxmoxifen and AZ-1 were more potent than paclitaxel to</text>
<text top="602" left="315" width="241" height="9" font="font4" id="p1_t53" reading_order_no="148" segment_no="11" tag_type="text">our local cell line BC-M1. This indicates that the BC-M1</text>
<text top="614" left="315" width="241" height="9" font="font4" id="p1_t54" reading_order_no="149" segment_no="11" tag_type="text">cell is more sensitive to the hormone antagonist drug and</text>
<text top="626" left="315" width="241" height="9" font="font4" id="p1_t55" reading_order_no="150" segment_no="11" tag_type="text">our bioreductive compound AZ-1 than to a nonhormone</text>
<text top="637" left="315" width="241" height="9" font="font4" id="p1_t56" reading_order_no="151" segment_no="11" tag_type="text">antagonist such as paclitaxel. We assumed that the BC-M1</text>
<text top="649" left="315" width="240" height="9" font="font4" id="p1_t57" reading_order_no="152" segment_no="11" tag_type="text">cell is an estrogen receptor-positive cell line. According to</text>
<text top="661" left="315" width="241" height="9" font="font4" id="p1_t58" reading_order_no="155" segment_no="11" tag_type="text"><a href="">the results of Figs 4 and 5,</a> the apoptosis phenomena were</text>
<text top="673" left="315" width="241" height="9" font="font4" id="p1_t59" reading_order_no="156" segment_no="11" tag_type="text">observed in BC-M1 cells induced by AZ-1 for 24 hours.</text>
<text top="684" left="315" width="241" height="9" font="font4" id="p1_t60" reading_order_no="157" segment_no="11" tag_type="text">We saw the apoptotic bodies increasing in direct</text>
<text top="696" left="315" width="241" height="9" font="font4" id="p1_t61" reading_order_no="158" segment_no="11" tag_type="text">proportion with the concentration of AZ-1 based on the</text>
<text top="708" left="315" width="26" height="9" font="font4" id="p1_t62" reading_order_no="153" segment_no="11" tag_type="text">sub-G</text>
<text top="712" left="341" width="6" height="6" font="font5" id="p1_t63" reading_order_no="154" segment_no="11" tag_type="text">1 </text>
<text top="708" left="348" width="208" height="9" font="font4" id="p1_t64" reading_order_no="159" segment_no="11" tag_type="text">area measurement and Hoechst staining (Figs<a href=""> 4</a></text>
<text top="720" left="315" width="241" height="9" font="font4" id="p1_t65" reading_order_no="160" segment_no="11" tag_type="text">an<a href="">d 5)</a>. The apoptotic bodies were increasing slightly in 0.5</text>
<text top="85" left="57" width="31" height="7" font="font0" id="p1_t66" reading_order_no="2" segment_no="3" tag_type="title"><b>Figure 9</b></text>
<text top="278" left="57" width="235" height="7" font="font6" id="p1_t67" reading_order_no="36" segment_no="6" tag_type="text">The enzyme activity of caspase 3 in BC-M1 cells was induced by bis-</text>
<text top="278" left="57" width="103" height="7" font="font6" id="p1_t68" reading_order_no="35" segment_no="6" tag_type="text">aziridinylnapthoquinone (AZ-1)</text>
<text top="288" left="57" width="241" height="7" font="font2" id="p1_t69" reading_order_no="37" segment_no="6" tag_type="text">aziridinylnapthoquinone (AZ-1). Cells were seeded for 24 hours before </text>
<text top="297" left="57" width="238" height="7" font="font2" id="p1_t70" reading_order_no="38" segment_no="6" tag_type="text">the addition of AZ-1 in various concentrations. The cell lysate was pre-</text>
<text top="307" left="57" width="241" height="7" font="font2" id="p1_t71" reading_order_no="39" segment_no="6" tag_type="text">pared for analysis by a CPP32/caspase 3 colorimetric assay kit accord-</text>
<text top="316" left="57" width="239" height="7" font="font2" id="p1_t72" reading_order_no="40" segment_no="6" tag_type="text">ing to the manufacturer's instructions. The enzyme activity is shown as </text>
<text top="326" left="57" width="132" height="7" font="font2" id="p1_t73" reading_order_no="41" segment_no="6" tag_type="text">the fold increase relative to the control.</text>
<text top="232" left="94" width="5" height="10" font="font7" id="p1_t74" reading_order_no="26" segment_no="2" tag_type="figure">0</text>
<text top="210" left="87" width="12" height="10" font="font7" id="p1_t75" reading_order_no="25" segment_no="2" tag_type="figure">0.5</text>
<text top="189" left="94" width="5" height="10" font="font7" id="p1_t76" reading_order_no="24" segment_no="2" tag_type="figure">1</text>
<text top="167" left="87" width="12" height="10" font="font7" id="p1_t77" reading_order_no="23" segment_no="2" tag_type="figure">1.5</text>
<text top="145" left="94" width="5" height="10" font="font7" id="p1_t78" reading_order_no="22" segment_no="2" tag_type="figure">2</text>
<text top="124" left="87" width="12" height="10" font="font7" id="p1_t79" reading_order_no="21" segment_no="2" tag_type="figure">2.5</text>
<text top="102" left="94" width="5" height="10" font="font7" id="p1_t80" reading_order_no="20" segment_no="2" tag_type="figure">3</text>
<text top="243" left="103" width="4" height="8" font="font8" id="p1_t81" reading_order_no="27" segment_no="2" tag_type="figure">0</text>
<text top="243" left="150" width="4" height="8" font="font8" id="p1_t82" reading_order_no="28" segment_no="2" tag_type="figure">1</text>
<text top="243" left="194" width="4" height="8" font="font8" id="p1_t83" reading_order_no="29" segment_no="2" tag_type="figure">2</text>
<text top="243" left="240" width="4" height="8" font="font8" id="p1_t84" reading_order_no="30" segment_no="2" tag_type="figure">3</text>
<text top="243" left="285" width="4" height="8" font="font8" id="p1_t85" reading_order_no="31" segment_no="2" tag_type="figure">4</text>
<text top="258" left="176" width="28" height="11" font="font9" id="p1_t86" reading_order_no="32" segment_no="2" tag_type="figure">AZ-1 (</text>
<text top="255" left="204" width="6" height="14" font="font10" id="p1_t87" reading_order_no="33" segment_no="2" tag_type="figure">µ</text>
<text top="258" left="210" width="13" height="11" font="font9" id="p1_t88" reading_order_no="34" segment_no="2" tag_type="figure">M)</text>
<text top="196" left="66" width="0" height="10" font="font11" id="p1_t89" reading_order_no="8" segment_no="2" tag_type="figure">C</text>
<text top="189" left="66" width="0" height="10" font="font11" id="p1_t90" reading_order_no="7" segment_no="2" tag_type="figure">as</text>
<text top="181" left="66" width="0" height="10" font="font11" id="p1_t91" reading_order_no="6" segment_no="2" tag_type="figure">pas</text>
<text top="168" left="66" width="0" height="10" font="font11" id="p1_t92" reading_order_no="5" segment_no="2" tag_type="figure">e</text>
<text top="161" left="66" width="0" height="10" font="font11" id="p1_t93" reading_order_no="4" segment_no="2" tag_type="figure">activ</text>
<text top="142" left="66" width="0" height="10" font="font11" id="p1_t94" reading_order_no="3" segment_no="2" tag_type="figure">ity</text>
<text top="213" left="78" width="0" height="10" font="font11" id="p1_t95" reading_order_no="19" segment_no="2" tag_type="figure">(f</text>
<text top="206" left="78" width="0" height="10" font="font11" id="p1_t96" reading_order_no="18" segment_no="2" tag_type="figure">ol</text>
<text top="199" left="78" width="0" height="10" font="font11" id="p1_t97" reading_order_no="17" segment_no="2" tag_type="figure">ds</text>
<text top="188" left="78" width="0" height="10" font="font11" id="p1_t98" reading_order_no="16" segment_no="2" tag_type="figure">re</text>
<text top="180" left="78" width="0" height="10" font="font11" id="p1_t99" reading_order_no="15" segment_no="2" tag_type="figure">lativ</text>
<text top="162" left="78" width="0" height="10" font="font11" id="p1_t100" reading_order_no="14" segment_no="2" tag_type="figure">e</text>
<text top="156" left="78" width="0" height="10" font="font11" id="p1_t101" reading_order_no="13" segment_no="2" tag_type="figure">to</text>
<text top="145" left="78" width="0" height="10" font="font11" id="p1_t102" reading_order_no="12" segment_no="2" tag_type="figure">co</text>
<text top="136" left="78" width="0" height="10" font="font11" id="p1_t103" reading_order_no="11" segment_no="2" tag_type="figure">ntr</text>
<text top="125" left="78" width="0" height="10" font="font11" id="p1_t104" reading_order_no="10" segment_no="2" tag_type="figure">ol</text>
<text top="118" left="78" width="0" height="10" font="font11" id="p1_t105" reading_order_no="9" segment_no="2" tag_type="figure">)</text>
<text top="85" left="315" width="36" height="7" font="font0" id="p1_t106" reading_order_no="72" segment_no="4" tag_type="title"><b>Figure 10</b></text>
<text top="284" left="315" width="75" height="7" font="font6" id="p1_t107" reading_order_no="115" segment_no="7" tag_type="text">Plot of the ratio of CH</text>
<text top="287" left="390" width="3" height="5" font="font12" id="p1_t108" reading_order_no="116" segment_no="7" tag_type="text">2</text>
<text top="284" left="393" width="15" height="7" font="font6" id="p1_t109" reading_order_no="117" segment_no="7" tag_type="text">/CH</text>
<text top="287" left="408" width="5" height="5" font="font12" id="p1_t110" reading_order_no="118" segment_no="7" tag_type="text">3 </text>
<text top="284" left="412" width="138" height="7" font="font6" id="p1_t111" reading_order_no="120" segment_no="7" tag_type="text">peak area according to NMR spectra as </text>
<text top="284" left="315" width="227" height="7" font="font6" id="p1_t112" reading_order_no="119" segment_no="7" tag_type="text">the dose of bis-aziridinylnapthoquinone (AZ-1)-treated BC-M1 cells</text>
<text top="293" left="315" width="231" height="7" font="font2" id="p1_t113" reading_order_no="121" segment_no="7" tag_type="text">the dose of bis-aziridinylnapthoquinone (AZ-1)-treated BC-M1 cells. </text>
<text top="303" left="315" width="238" height="7" font="font2" id="p1_t114" reading_order_no="122" segment_no="7" tag_type="text">Cells were seeded for 24 hours before the addition of AZ-1 in various </text>
<text top="312" left="315" width="107" height="7" font="font2" id="p1_t115" reading_order_no="123" segment_no="7" tag_type="text">concentrations. The ratio of CH</text>
<text top="316" left="422" width="3" height="5" font="font13" id="p1_t116" reading_order_no="124" segment_no="7" tag_type="text">2</text>
<text top="312" left="425" width="15" height="7" font="font2" id="p1_t117" reading_order_no="125" segment_no="7" tag_type="text">/CH</text>
<text top="316" left="440" width="5" height="5" font="font13" id="p1_t118" reading_order_no="126" segment_no="7" tag_type="text">3 </text>
<text top="312" left="444" width="94" height="7" font="font2" id="p1_t119" reading_order_no="127" segment_no="7" tag_type="text">signal intensity was plotted </text>
<text top="322" left="315" width="146" height="7" font="font2" id="p1_t120" reading_order_no="128" segment_no="7" tag_type="text">against the various concentrations of AZ-1.</text>
<text top="240" left="349" width="10" height="8" font="font14" id="p1_t121" reading_order_no="106" segment_no="5" tag_type="figure">0.4</text>
<text top="223" left="349" width="10" height="8" font="font14" id="p1_t122" reading_order_no="105" segment_no="5" tag_type="figure">0.6</text>
<text top="205" left="349" width="10" height="8" font="font14" id="p1_t123" reading_order_no="104" segment_no="5" tag_type="figure">0.8</text>
<text top="188" left="355" width="4" height="8" font="font14" id="p1_t124" reading_order_no="103" segment_no="5" tag_type="figure">1</text>
<text top="171" left="349" width="10" height="8" font="font14" id="p1_t125" reading_order_no="102" segment_no="5" tag_type="figure">1.2</text>
<text top="154" left="349" width="10" height="8" font="font14" id="p1_t126" reading_order_no="101" segment_no="5" tag_type="figure">1.4</text>
<text top="137" left="349" width="10" height="8" font="font14" id="p1_t127" reading_order_no="100" segment_no="5" tag_type="figure">1.6</text>
<text top="120" left="349" width="10" height="8" font="font14" id="p1_t128" reading_order_no="99" segment_no="5" tag_type="figure">1.8</text>
<text top="102" left="355" width="4" height="8" font="font14" id="p1_t129" reading_order_no="98" segment_no="5" tag_type="figure">2</text>
<text top="251" left="363" width="4" height="8" font="font14" id="p1_t130" reading_order_no="107" segment_no="5" tag_type="figure">0</text>
<text top="251" left="407" width="10" height="8" font="font14" id="p1_t131" reading_order_no="108" segment_no="5" tag_type="figure">0.5</text>
<text top="251" left="457" width="4" height="8" font="font14" id="p1_t132" reading_order_no="109" segment_no="5" tag_type="figure">1</text>
<text top="251" left="502" width="10" height="8" font="font14" id="p1_t133" reading_order_no="110" segment_no="5" tag_type="figure">1.5</text>
<text top="251" left="550" width="4" height="8" font="font14" id="p1_t134" reading_order_no="111" segment_no="5" tag_type="figure">2</text>
<text top="266" left="439" width="21" height="8" font="font14" id="p1_t135" reading_order_no="112" segment_no="5" tag_type="figure">AZ-1 (</text>
<text top="264" left="460" width="5" height="10" font="font15" id="p1_t136" reading_order_no="113" segment_no="5" tag_type="figure">µ</text>
<text top="266" left="465" width="10" height="8" font="font14" id="p1_t137" reading_order_no="114" segment_no="5" tag_type="figure">M)</text>
<text top="207" left="324" width="0" height="10" font="font16" id="p1_t138" reading_order_no="83" segment_no="5" tag_type="figure">Pe</text>
<text top="198" left="324" width="0" height="10" font="font16" id="p1_t139" reading_order_no="82" segment_no="5" tag_type="figure">ak</text>
<text top="187" left="324" width="0" height="10" font="font16" id="p1_t140" reading_order_no="81" segment_no="5" tag_type="figure">of</text>
<text top="177" left="324" width="0" height="10" font="font16" id="p1_t141" reading_order_no="80" segment_no="5" tag_type="figure">C</text>
<text top="170" left="324" width="0" height="10" font="font16" id="p1_t142" reading_order_no="79" segment_no="5" tag_type="figure">H</text>
<text top="167" left="326" width="0" height="7" font="font17" id="p1_t143" reading_order_no="78" segment_no="5" tag_type="figure">2</text>
<text top="161" left="324" width="0" height="10" font="font16" id="p1_t144" reading_order_no="77" segment_no="5" tag_type="figure">/C</text>
<text top="152" left="324" width="0" height="10" font="font16" id="p1_t145" reading_order_no="76" segment_no="5" tag_type="figure">H</text>
<text top="148" left="326" width="0" height="7" font="font17" id="p1_t146" reading_order_no="75" segment_no="5" tag_type="figure">3</text>
<text top="140" left="324" width="0" height="10" font="font16" id="p1_t147" reading_order_no="74" segment_no="5" tag_type="figure">ra</text>
<text top="133" left="324" width="0" height="10" font="font16" id="p1_t148" reading_order_no="73" segment_no="5" tag_type="figure">tio</text>
<text top="215" left="337" width="0" height="10" font="font16" id="p1_t149" reading_order_no="97" segment_no="5" tag_type="figure">(r</text>
<text top="209" left="337" width="0" height="10" font="font16" id="p1_t150" reading_order_no="96" segment_no="5" tag_type="figure">el</text>
<text top="202" left="337" width="0" height="10" font="font16" id="p1_t151" reading_order_no="95" segment_no="5" tag_type="figure">at</text>
<text top="196" left="337" width="0" height="10" font="font16" id="p1_t152" reading_order_no="94" segment_no="5" tag_type="figure">iv</text>
<text top="188" left="337" width="0" height="10" font="font16" id="p1_t153" reading_order_no="93" segment_no="5" tag_type="figure">e</text>
<text top="182" left="337" width="0" height="10" font="font16" id="p1_t154" reading_order_no="92" segment_no="5" tag_type="figure">fo</text>
<text top="174" left="337" width="0" height="10" font="font16" id="p1_t155" reading_order_no="91" segment_no="5" tag_type="figure">ld</text>
<text top="167" left="337" width="0" height="10" font="font16" id="p1_t156" reading_order_no="90" segment_no="5" tag_type="figure">s</text>
<text top="161" left="337" width="0" height="10" font="font16" id="p1_t157" reading_order_no="89" segment_no="5" tag_type="figure">ov</text>
<text top="152" left="337" width="0" height="10" font="font16" id="p1_t158" reading_order_no="88" segment_no="5" tag_type="figure">er</text>
<text top="142" left="337" width="0" height="10" font="font16" id="p1_t159" reading_order_no="87" segment_no="5" tag_type="figure">co</text>
<text top="133" left="337" width="0" height="10" font="font16" id="p1_t160" reading_order_no="86" segment_no="5" tag_type="figure">nt</text>
<text top="126" left="337" width="0" height="10" font="font16" id="p1_t161" reading_order_no="85" segment_no="5" tag_type="figure">ro</text>
<text top="118" left="337" width="0" height="10" font="font16" id="p1_t162" reading_order_no="84" segment_no="5" tag_type="figure">l)</text>
</page>
</pdf2xml>
